Want to see BCLI full AI Analyst Report?
Technical Sentiment
Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Brainstorm Cell Therapeutics’s (BCLI) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting Brainstorm Cell Therapeutics is a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 20-Day exponential moving average is 1.02, while Brainstorm Cell Therapeutics’s (BCLI) share price is $1, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) 50-Day exponential moving average is 0.96, while Brainstorm Cell Therapeutics’s (BCLI) share price is $1, making it a Buy.
Brainstorm Cell Therapeutics (BCLI) Pivot Points
Classic
0.76
0.87
1.04
1.15
1.32
1.43
1.60
Fibonacci
0.87
0.98
1.05
1.15
1.26
1.33
1.43
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Brainstorm Cell Therapeutics (BCLI) Moving Averages
MA5
1.07Buy
1.11Buy
MA10
1.11Buy
1.07Buy
MA20
0.96Buy
1.02Buy
MA50
0.99Buy
0.96Buy
MA100
0.87Buy
0.90Buy
MA200
0.76Buy
0.81Buy
Brainstorm Cell Therapeutics’s (BCLI) 10-Day exponential moving average is 1.07, while Brainstorm Cell Therapeutics’s (BCLI) share price is $1, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) 100-Day exponential moving average is 0.90, while Brainstorm Cell Therapeutics’s (BCLI) share price is $1, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $1 and Brainstorm Cell Therapeutics’s (BCLI) 50-day simple moving average is 0.99, creating a Buy signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $1 and Brainstorm Cell Therapeutics’s (BCLI) 100-day simple moving average is 0.87, creating a Buy signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $1 and Brainstorm Cell Therapeutics’s (BCLI) 200-day simple moving average is 0.76, creating a Buy signal.
Brainstorm Cell Therapeutics (BCLI) Technical Indicators
RSI (14)
57.64
Neutral
STOCH (9,6)
43.74
Neutral
STOCHRSI (14)
50.00
Neutral
MACD (12,26)
0.05
Sell
ADX (14)
34.34
Neutral
Williams %R
-44.59
Buy
CCI (14)
99.59
Neutral
ATR (14)
0.15
-
Ultimate Oscillator
55.79
Neutral
ROC
46.84
Buy
Brainstorm Cell Therapeutics’s (BCLI) Relative Strength Index (RSI) is 57.64, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Trend Strength Indicator (ADX) is 34.34, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Commodity Channel Index (CCI) is 99.59, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Price Rate of Change (ROC) is 46.84, creating a Buy signal.
FAQ
Is BCLI a Buy, Hold, or Sell?
Based on BCLI’s technical indicators, BCLI is a Strong Buy.
What is BCLI’s RSI (14)?
BCLI’s RSI (14) is 57.64, which suggests BCLI is a Neutral.
What is BCLI’s MACD?
BCLI’s MACD is 0.05, which suggests BCLI is a Sell.
What is BCLI’s 5-day moving average?
BCLI’s 5-day moving average is 1.07, which suggests BCLI is a Buy.
What is BCLI’s 20-day moving average?
BCLI 20-day moving average is 0.96, which suggests BCLI is a Buy.
What is BCLI’s 50-day moving average?
BCLI’s 50-day moving average is 0.99, which suggests BCLI is a Buy.
What is BCLI’s 200-day moving average?
BCLI’s 200-day moving average is 0.76, which suggests BCLI is a Buy.
What is BCLI’s Williams % R (14)?
BCLI’s Williams % R (14) is -44.59, which suggests BCLI is a Buy.
What is BCLI’s CCI (14)?
BCLI’s CCI (14) is 99.59, which suggests BCLI is a Neutral.